These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impaired fibrinolysis and insulin resistance in patients with hypertension. Jeng JR; Sheu WH; Jeng CY; Huang SH; Shieh SM Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180 [TBL] [Abstract][Full Text] [Related]
4. Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma. Urano T; Kojima Y; Takahashi M; Serizawa K; Sakakibara K; Takada Y; Takada A Jpn J Physiol; 1993; 43(2):221-8. PubMed ID: 8355419 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait. Akanji AO; Abdullah A; Tahzeeb S Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544 [TBL] [Abstract][Full Text] [Related]
6. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309 [TBL] [Abstract][Full Text] [Related]
7. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia. Glueck CJ; Glueck HI; Tracy T; Speirs J; Stroop D Metabolism; 1993 Nov; 42(11):1410-9. PubMed ID: 8231835 [TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic activity in Chinese patients with diabetes or hyperlipidemia in comparison with healthy controls. Ho CH; Jap TS Thromb Haemost; 1991 Jan; 65(1):3-6. PubMed ID: 1902595 [TBL] [Abstract][Full Text] [Related]
9. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease. Smith FB; Lee AJ; Rumley A; Fowkes FG; Lowe GD Atherosclerosis; 1995 May; 115(1):35-43. PubMed ID: 7669086 [TBL] [Abstract][Full Text] [Related]
10. Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population. Sundell IB; Nilsson TK; Hallmans G; Hellsten G; Dahlén GH Atherosclerosis; 1989 Nov; 80(1):9-16. PubMed ID: 2532510 [TBL] [Abstract][Full Text] [Related]
11. Relationship between endothelial function and fibrinolysis in early hypertension. Tomiyama H; Kimura Y; Mitsuhashi H; Kinouchi T; Yoshida H; Kushiro T; Doba N Hypertension; 1998 Jan; 31(1 Pt 2):321-7. PubMed ID: 9453323 [TBL] [Abstract][Full Text] [Related]
12. Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus. García Frade LJ; de la Calle H; Torrado MC; Lara JI; Cuellar L; García Avello A Thromb Res; 1990 Jul; 59(1):51-9. PubMed ID: 2119076 [TBL] [Abstract][Full Text] [Related]
13. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1. Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051 [TBL] [Abstract][Full Text] [Related]
14. Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol. Jansson JH; Johansson B; Boman K; Nilsson TK Eur J Clin Pharmacol; 1991; 40(4):321-6. PubMed ID: 1828764 [TBL] [Abstract][Full Text] [Related]
15. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity]. Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860 [TBL] [Abstract][Full Text] [Related]
16. The effect of body build, diet and endocrine factors on the extrinsic fibrinolytic system in healthy young women. Sundell IB; Nilsson TK; Hallmans G; Nygren C Scand J Clin Lab Invest; 1988 Oct; 48(6):557-64. PubMed ID: 3146134 [TBL] [Abstract][Full Text] [Related]
17. The association of fibrinolysis and hyperlipidaemia with quantitative sensory tests in an epidemiological study of Swedish type 1 diabetic patients. Lithner F; Bergenheim T; Borssén B; Dahlén G; Nilsson TK Diabet Med; 1995 Jul; 12(7):590-4. PubMed ID: 7554780 [TBL] [Abstract][Full Text] [Related]
18. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism. Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786 [TBL] [Abstract][Full Text] [Related]
19. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038 [TBL] [Abstract][Full Text] [Related]
20. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A; Ruusuvaara L Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]